4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-058694
Director bought 67,881 shares at an average $1.02 ($69,233)
From the SEC's structured data for this filing
Trades in this filing
Lamond David · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-12 | Purchase : show line 1 in the form | +300 | $1.00 | $300 | 2,279,964 | I |
| 2023-12-12 | Purchase : show line 2 in the form | +22,327 | $1.02 | $22,774 | 2,302,291 | D |
| 2023-12-13 | Purchase : show line 3 in the form | +22,627 | $1.00 | $22,627 | 2,324,918 | I |
| 2023-12-14 | Purchase : show line 4 in the form | +22,627 | $1.04 | $23,532 | 2,347,545 | I |
| Open-market purchases · 67,881 sh · avg $1.02 · $69,233 | ||||||
Loading xslF345X05/doc4.xml…